Essential Partners’s Apogee Therapeutics APGE Stock Holding History

Essential Partners’s Portfolio APGE Stock Details APGE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	–	Sell	-2	Closed	-$265	–	2861
2026 Q2	$265	Buy	+2	New	+$180	﹤0.01%	2591

Other funds holding APGE

IFP Advisors Tampa, Florida $5.86B AUM 20.09% 1-Year Est. Return

Allworth Financial Folsom, California $28.2B AUM 13.34% 1-Year Est. Return

Essential Partners's APGE Position: Q3 2026 in Review

Essential Partners sold out of Apogee Therapeutics (APGE) in Q3 2026, closing a stake of 2 shares — an estimated $265 sold.

Essential Partners first reported a position in APGE in Q2 2026 and held it in 1 quarter. The position peaked at $265 in Q2 2026. 2 funds tracked by Wall St. Rank hold APGE as of Q3 2026.

Essential Partners reported no remaining Apogee Therapeutics position as of Q3 2026 after selling out during the quarter.
Essential Partners sold 2 Apogee Therapeutics shares in Q3 2026, an estimated $265.
Essential Partners first reported a position in Apogee Therapeutics in Q2 2026 and held it in 1 quarter.
Essential Partners's Apogee Therapeutics position peaked at $265 in Q2 2026.
2 funds tracked by Wall St. Rank held Apogee Therapeutics as of Q3 2026.

Based on Essential Partners's 13F filing for Q3 2026, filed 14 Oct 2026.